StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2022 - 09 - 05
1
2022 - 08 - 23
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 09
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 03 - 25
1
2021 - 03 - 19
1
2021 - 03 - 11
1
Sector
Commercial services
2
Health technology
15
Tags
Global
2
Hereditary angioedema
2
Market
2
N/a
15
Entities
Abbott laboratories
254
Abbvie inc.
211
Alnylam pharmaceuticals, inc.
78
Alphabet inc.
37
Amarin corporation plc
36
Amgen inc.
170
Astellas pharma inc
70
Astrazeneca plc
214
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
30
Baxter international inc.
45
Becton, dickinson and company
34
Biogen inc.
53
Biomarin pharmaceutical inc.
29
Biontech se
168
Blueprint medicines corporation
20
Boston scientific corporation
25
Bristol-myers squibb company
119
Byline bancorp, inc.
26
Clovis oncology, inc.
20
Csl ltd
22
Denali therapeutics inc.
22
Eli lilly and company
335
Endo international plc
20
Galapagos nv
41
Gilead sciences, inc.
64
Glaxosmithkline plc
335
Igm biosciences, inc.
37
Incyte corporation
121
Innate pharma s.a.
109
Innate pharma sa
81
Johnson & johnson
580
Karyopharm therapeutics inc.
25
Kymera therapeutics, inc.
29
Medtronic plc
45
Mobiv acquisition corp
65
Moderna, inc.
34
Morphosys ag
41
Nektar therapeutics
48
Novartis ag
330
Novo nordisk a/s
139
Oncocyte corporation
37
Orange
49
Perrigo company
113
Pfizer, inc.
153
Provention bio, inc.
283
Ptc therapeutics, inc.
37
Rallybio corp
36
Rcf acquisition corp.
83
Reckitt benckiser group plc
21
Regeneron pharmaceuticals, inc.
256
Sanofi
4559
Takeda pharmaceutical company limited
60
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
36
Thermo fisher scientific inc
43
Translate bio, inc.
21
Vaxart, inc.
38
Viatris inc.
87
Vir biotechnology, inc.
22
Symbols
ABBV
13
ADVM
2
AMGN
13
ARWR
2
BCRX
220
BMRN
3
BMY
13
CLSD
2
CNTG
2
ENDP
1
ENDPQ
1
GILD
13
GLYC
1
IMGN
1
IONS
2
JNJ
2
LLY
13
OMER
13
OTIC
13
PFE
14
PHAS
1
REGN
6
RPRX
4
SCYX
1
SNY
15
SNYNF
2
SUPN
3
TAK
2
XERS
10
Exchanges
Nasdaq
15
Nyse
15
Crawled Date
2022 - 09 - 05
1
2022 - 08 - 23
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
2021 - 03 - 25
1
2021 - 03 - 19
1
2021 - 03 - 11
1
Crawled Time
00:00
4
10:51
1
11:00
1
12:34
1
13:07
1
13:17
1
13:27
1
14:03
1
15:49
1
17:43
1
18:32
1
19:00
1
Source
www.fda.gov
13
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Biocryst pharmaceuticals, inc.
symbols :
SNY
save search
Outlook on the Hereditary Angioedema Global Market to 2030 - Size, Share, Outlook, and Opportunity Analysis
Published:
2022-09-05
(Crawled : 11:00)
- prnewswire.com
CNTG
|
$0.475
-1.04%
-1.05%
19K
|
Commercial Services
|
Email alert
Add to watchlist
ADVM
|
News
|
$10.19
-7.36%
-7.95%
310K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
IONS
|
$42.455
1.47%
1.45%
730K
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
ARWR
|
$23.285
-2.08%
-2.13%
810K
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
Email alert
Add to watchlist
global
market
hereditary angioedema
Global Hereditary Angioedema Market to Surpass US$ 4,897.51 Million by 2030 - Coherent Market Insights
Published:
2022-08-23
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
10.88%
|
O:
-4.66%
H:
0.0%
C:
-1.69%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-4.13%
|
O:
-0.79%
H:
0.98%
C:
0.72%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
14.96%
|
O:
-1.48%
H:
0.0%
C:
0.0%
IONS
|
$42.455
1.47%
1.45%
730K
|
Health Technology
|
-4.61%
|
O:
0.71%
H:
2.81%
C:
1.31%
CNTG
|
$0.475
-1.04%
-1.05%
19K
|
Commercial Services
|
-68.0%
|
O:
3.33%
H:
0.0%
C:
-3.87%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-69.69%
|
O:
-0.97%
H:
5.66%
C:
3.49%
ARWR
|
$23.285
-2.08%
-2.13%
810K
|
Health Technology
|
-42.31%
|
O:
0.32%
H:
4.28%
C:
3.39%
ADVM
|
News
|
$10.19
-7.36%
-7.95%
310K
|
Health Technology
|
780.0%
|
O:
-1.6%
H:
4.07%
C:
1.63%
global
market
hereditary angioedema
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-07-23
(Crawled : 00:00)
- fda.gov
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
Email alert
Add to watchlist
SCYX
|
$1.495
-3.55%
-3.68%
88K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-24
(Crawled : 14:03)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.6%
|
O:
0.23%
H:
0.52%
C:
0.13%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
240.42%
|
O:
8.21%
H:
1.89%
C:
-0.83%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-24.93%
|
O:
0.31%
H:
1.15%
C:
0.6%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
48.72%
|
O:
0.37%
H:
1.55%
C:
0.28%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-54.36%
|
O:
0.0%
H:
10.77%
C:
10.77%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.64%
|
O:
0.29%
H:
0.8%
C:
0.17%
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-80.0%
|
O:
0.32%
H:
0.87%
C:
0.26%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
0.57%
|
O:
0.18%
H:
2.2%
C:
0.61%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-74.22%
|
O:
0.06%
H:
0.35%
C:
0.0%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
14.59%
|
O:
0.71%
H:
1.09%
C:
0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.18%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
238.16%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.3%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
49.88%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-56.69%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-10.97%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-79.48%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
0.63%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-72.44%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
14.61%
|
O:
0.4%
H:
0.53%
C:
0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-09
(Crawled : 10:51)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.25%
|
O:
0.39%
H:
2.15%
C:
2.08%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
234.87%
|
O:
0.29%
H:
2.43%
C:
2.1%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-23.09%
|
O:
0.5%
H:
2.39%
C:
2.16%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
50.92%
|
O:
0.48%
H:
1.36%
C:
0.99%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-54.36%
|
O:
7.18%
H:
4.52%
C:
-4.07%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.6%
|
O:
0.88%
H:
0.74%
C:
0.5%
OTIC
|
$0.077
|
Health Technology
|
-96.75%
|
O:
-0.84%
H:
5.93%
C:
0.42%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-80.5%
|
O:
0.95%
H:
2.0%
C:
0.25%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-0.71%
|
O:
0.09%
H:
2.4%
C:
1.6%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-74.3%
|
O:
0.82%
H:
2.39%
C:
-1.11%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
15.51%
|
O:
0.46%
H:
1.42%
C:
0.67%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-24
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-34.12%
|
O:
0.33%
H:
0.15%
C:
-0.67%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
269.75%
|
O:
0.56%
H:
1.3%
C:
0.01%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.94%
|
O:
0.33%
H:
1.03%
C:
0.03%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
46.0%
|
O:
0.4%
H:
0.19%
C:
-0.58%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-48.7%
|
O:
-1.15%
H:
1.46%
C:
-4.66%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.56%
|
O:
0.02%
H:
0.3%
C:
-0.3%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
79.06%
|
O:
0.6%
H:
0.0%
C:
-1.82%
OTIC
|
$0.077
|
Health Technology
|
-96.87%
|
O:
1.21%
H:
0.0%
C:
-7.2%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-79.25%
|
O:
0.94%
H:
1.4%
C:
1.06%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-2.5%
|
O:
0.51%
H:
0.2%
C:
-2.42%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-68.4%
|
O:
0.43%
H:
1.44%
C:
-2.16%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
8.98%
|
O:
-0.18%
H:
1.17%
C:
-1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-18
(Crawled : 13:27)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-34.38%
|
O:
0.17%
H:
0.41%
C:
-0.32%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
277.97%
|
O:
-0.27%
H:
0.69%
C:
-0.19%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-25.16%
|
O:
-0.06%
H:
0.58%
C:
0.28%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
45.04%
|
O:
-0.67%
H:
1.54%
C:
0.95%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-48.85%
|
O:
0.0%
H:
5.46%
C:
3.16%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.02%
|
O:
0.22%
H:
0.1%
C:
-0.26%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
73.24%
|
O:
-0.14%
H:
0.0%
C:
-1.3%
OTIC
|
$0.077
|
Health Technology
|
-96.73%
|
O:
-0.84%
H:
4.63%
C:
1.7%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-82.63%
|
O:
0.06%
H:
1.35%
C:
-0.06%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-2.95%
|
O:
0.49%
H:
0.66%
C:
-0.81%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-69.54%
|
O:
-0.76%
H:
4.91%
C:
0.77%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
8.38%
|
O:
-0.12%
H:
0.4%
C:
-0.48%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-12
(Crawled : 17:43)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-33.11%
|
O:
0.23%
H:
1.22%
C:
0.63%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
279.49%
|
O:
0.0%
H:
0.46%
C:
-0.8%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-23.76%
|
O:
0.26%
H:
1.24%
C:
0.16%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
47.57%
|
O:
-0.03%
H:
1.0%
C:
0.1%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-47.95%
|
O:
-2.68%
H:
7.56%
C:
0.05%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.41%
|
O:
-0.46%
H:
0.95%
C:
0.12%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
81.03%
|
O:
-0.84%
H:
3.35%
C:
2.04%
OTIC
|
$0.077
|
Health Technology
|
-96.28%
|
O:
1.92%
H:
4.25%
C:
1.42%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-83.23%
|
O:
-1.41%
H:
2.86%
C:
-1.76%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-0.28%
|
O:
-0.7%
H:
1.8%
C:
1.05%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-63.92%
|
O:
-1.98%
H:
6.47%
C:
4.96%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
8.42%
|
O:
-0.35%
H:
0.92%
C:
-0.23%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-22
(Crawled : 12:34)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-33.42%
|
O:
-0.13%
H:
0.05%
C:
-2.13%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
287.04%
|
O:
-0.5%
H:
0.67%
C:
-1.55%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.13%
|
O:
-0.26%
H:
0.62%
C:
0.26%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
53.01%
|
O:
-0.14%
H:
0.4%
C:
-0.54%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-54.12%
|
O:
0.26%
H:
4.37%
C:
-0.26%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-10.29%
|
O:
-0.93%
H:
0.27%
C:
0.17%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
79.14%
|
O:
-0.21%
H:
0.0%
C:
-2.96%
OTIC
|
$0.077
|
Health Technology
|
-96.61%
|
O:
0.0%
H:
3.51%
C:
0.88%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-83.85%
|
O:
0.1%
H:
0.31%
C:
-3.03%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
0.36%
|
O:
-0.46%
H:
0.05%
C:
-1.26%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-62.44%
|
O:
-0.34%
H:
8.09%
C:
3.7%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
5.7%
|
O:
-0.48%
H:
0.36%
C:
-0.97%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-20
(Crawled : 13:17)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.39%
|
O:
-0.46%
H:
1.26%
C:
0.72%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
289.71%
|
O:
0.41%
H:
1.62%
C:
0.11%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-25.32%
|
O:
-0.23%
H:
1.65%
C:
0.96%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
56.1%
|
O:
-0.45%
H:
1.33%
C:
0.84%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-52.28%
|
O:
-0.8%
H:
3.24%
C:
2.97%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.19%
|
O:
-0.08%
H:
0.42%
C:
0.42%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
81.58%
|
O:
-0.03%
H:
1.44%
C:
0.97%
OTIC
|
$0.077
|
Health Technology
|
-96.68%
|
O:
0.0%
H:
0.86%
C:
-1.72%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-82.91%
|
O:
-0.83%
H:
4.52%
C:
3.46%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
1.64%
|
O:
-0.23%
H:
1.22%
C:
0.88%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-61.95%
|
O:
-0.17%
H:
3.22%
C:
-3.31%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
6.86%
|
O:
-0.44%
H:
2.17%
C:
1.69%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-12
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-28.09%
|
O:
-0.33%
H:
1.52%
C:
1.34%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
300.59%
|
O:
-0.57%
H:
0.28%
C:
-0.88%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-21.75%
|
O:
-0.13%
H:
0.39%
C:
0.26%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
57.65%
|
O:
0.26%
H:
0.7%
C:
0.4%
XERS
|
$1.765
-0.84%
-0.85%
710K
|
Health Technology
|
-57.92%
|
O:
-0.47%
H:
0.12%
C:
-6.65%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-7.31%
|
O:
-0.33%
H:
0.12%
C:
-0.69%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
90.95%
|
O:
1.39%
H:
0.0%
C:
-1.86%
OTIC
|
$0.077
|
Health Technology
|
-96.53%
|
O:
0.0%
H:
0.9%
C:
-0.45%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-83.05%
|
O:
0.0%
H:
0.0%
C:
-7.13%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
2.95%
|
O:
-0.08%
H:
0.08%
C:
-0.61%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-57.1%
|
O:
-0.59%
H:
0.1%
C:
-6.4%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
9.88%
|
O:
-0.17%
H:
0.6%
C:
0.17%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-25
(Crawled : 15:49)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.09%
|
O:
0.11%
H:
0.39%
C:
0.06%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
310.2%
|
O:
0.46%
H:
1.46%
C:
1.15%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-21.36%
|
O:
1.12%
H:
0.0%
C:
-0.33%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
64.51%
|
O:
-0.16%
H:
1.21%
C:
0.95%
SUPN
|
$30.26
1.04%
1.02%
200K
|
Health Technology
|
19.09%
|
O:
-0.32%
H:
5.23%
C:
4.43%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-3.07%
|
O:
0.89%
H:
0.5%
C:
0.41%
OTIC
|
$0.077
|
Health Technology
|
-97.09%
|
O:
-1.88%
H:
2.3%
C:
0.0%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-84.11%
|
O:
-1.44%
H:
3.5%
C:
2.24%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
4.16%
|
O:
0.67%
H:
0.15%
C:
-1.22%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
23.19%
|
O:
-0.72%
H:
1.06%
C:
0.76%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-58.4%
|
O:
-4.08%
H:
7.03%
C:
6.04%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
11.44%
|
O:
0.64%
H:
0.2%
C:
-0.32%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-19
(Crawled : 18:32)
- fda.gov
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
SUPN
|
$30.26
1.04%
1.02%
200K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-11
(Crawled : 13:07)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-24.65%
|
O:
0.4%
H:
0.14%
C:
-1.03%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
259.72%
|
O:
0.52%
H:
0.36%
C:
-0.63%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-19.6%
|
O:
0.11%
H:
0.31%
C:
-1.07%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
56.98%
|
O:
0.12%
H:
0.46%
C:
-0.24%
SUPN
|
$30.26
1.04%
1.02%
200K
|
Health Technology
|
16.22%
|
O:
0.12%
H:
3.37%
C:
3.33%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.86%
|
O:
-0.31%
H:
0.63%
C:
0.08%
OTIC
|
$0.077
|
Health Technology
|
-97.21%
|
O:
1.81%
H:
2.48%
C:
1.42%
OMER
|
$3.04
-1.62%
-1.64%
250K
|
Health Technology
|
-83.84%
|
O:
2.46%
H:
1.25%
C:
0.36%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
4.88%
|
O:
-0.63%
H:
0.83%
C:
-0.66%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
18.85%
|
O:
0.28%
H:
1.23%
C:
-0.35%
BCRX
|
News
|
$4.22
-3.65%
-3.79%
4.4M
|
Health Technology
|
-67.82%
|
O:
1.62%
H:
0.65%
C:
-6.07%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
18.95%
|
O:
0.3%
H:
1.43%
C:
0.22%
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.